Phase II clinical study of CIM331 (hemodialysis)
Phase 2
- Conditions
- Pruritus in dialysis patients
- Registration Number
- JPRN-jRCT2080222909
- Lead Sponsor
- CHUGAI PHARMACEUTICAL CO., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
(1) Patients who receive hemodialysis three times a week.
(2) Patients who have been treated with systemic therapy or topical therapy for pruritus and who are inadequately controlled by them, or patients who have been treated with nalfurafine hydrochloride for pruritus.
Exclusion Criteria
Patients who are judged to be inadequate for this study participation by investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method